Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-479P is a pseudogene derived from the U6 small nuclear RNA (snRNA) gene family, located on human chromosome 4 [2][4]. It is a non-coding, non-functional RNA sequence that resembles the highly conserved U6 snRNA, which is a core component of the spliceosome involved in the splicing of pre-mRNA [3]. However, RNU6-479P does not encode a functional snRNA and is not known to be expressed or to play any biological or therapeutic role. It is one of many U6-related pseudogenes in the human genome, thought to be generated via retrotransposition events involving LINE elements, serving as a marker for retrotransposition activity rather than a biologically active molecule [5]. There is no evidence for its utility as a therapeutic target, biomarker, or involvement in disease, nor for any interacting drugs or associated safety concerns.
Not applicable (no targeting drugs known)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 479, pseudogene (RNU6-479P).